TRIMEDIK: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TRIMEDIK
Largest movements
- Tangible fixed assets -€33,416
down €33,416 (-4.6%), from €733,168 to €699,753
- Debts after one year -€36,566
down €36,566 (-6.4%), from €575,711 to €539,145
- Gross operating margin +€21,719
up €21,719 (+78.8%), from €27,550 to €49,269
- Other operating charges -€568
down €568 (-58.7%), from €968 to €400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €761,081 | €722,518 | -€38,563 | -5.1% |
| Fixed assets | 21/28 | €733,168 | €699,753 | -€33,416 | -4.6% |
| Tangible fixed assets | 22/27 | €733,168 | €699,753 | -€33,416 | -4.6% |
| Land and buildings | 22 | €733,168 | €699,753 | -€33,416 | -4.6% |
| Current assets | 29/58 | €27,912 | €22,765 | -€5,147 | -18.4% |
| Cash at bank and in hand | 54/58 | €27,028 | €21,854 | -€5,173 | -19.1% |
| Deferred charges and accrued income | 490/1 | €885 | €911 | +€26 | +2.9% |
| Total equity and liabilities | 10/49 | €761,081 | €722,518 | -€38,563 | -5.1% |
| Equity | 10/15 | €150,279 | €149,455 | -€823 | -0.5% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€49,721 | -€50,545 | -€823 | -1.7% |
| Amounts payable | 17/49 | €610,802 | €573,062 | -€37,740 | -6.2% |
| Amounts payable after more than one year | 17 | €575,711 | €539,145 | -€36,566 | -6.4% |
| Financial debts | 170/4 | €575,711 | €539,145 | -€36,566 | -6.4% |
| Amounts payable within one year | 42/48 | €35,092 | €33,918 | -€1,174 | -3.3% |
| Current portion of amounts payable after more than one year | 42 | €33,316 | €33,770 | +€454 | +1.4% |
| Trade debts | 44 | €1,715 | - | -€1,715 | |
| Suppliers | 440/4 | €1,715 | - | -€1,715 | |
| Other amounts payable | 47/48 | €60 | €147 | +€87 | +144.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,396 | €41,396 | = | 0.0% |
| Other operating charges | 640/8 | €968 | €400 | -€568 | -58.7% |
| Gross operating margin | 9900 | €27,550 | €49,269 | +€21,719 | +78.8% |
| Operating profit (loss) | 9901 | -€14,813 | €7,474 | +€22,286 | |
| Financial income | 75/76B | €7 | - | -€7 | |
| Recurring financial income | 75 | €7 | - | -€7 | |
| Financial charges | 65/66B | €8,131 | €8,297 | +€165 | +2.0% |
| Recurring financial charges | 65 | €8,131 | €8,297 | +€165 | +2.0% |
| Profit (loss) for the period before taxes | 9903 | -€22,937 | -€823 | +€22,114 | +96.4% |
| Profit (loss) for the period | 9904 | -€22,937 | -€823 | +€22,114 | +96.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€22,937 | -€823 | +€22,114 | +96.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.